Abiomed (ABMD:NASDAQ) Annual Reports & Investor Relations Material

Overview

Abiomed is a global leader in healthcare technology and innovation, with a focus on developing groundbreaking technologies to assist or replace the life-sustaining pumping function of the failing heart. Led by CEO, Chairman, and President Michael R. Minogue, the company offers a portfolio of products and services that provide healthcare professionals with an array of choices across a broad clinical spectrum. Abiomed's products range from the world's first total replacement heart to the World's Smallest Heart Pump, which is 1/100th the size of the heart and can be rapidly and easily inserted. The company is dedicated to bringing the most advanced and beneficial technology to patients and physicians alike with its mission of RECOVERING HEARTS AND SAVING LIVES.

Frequently Asked Questions

What is Abiomed's ticker?

Abiomed's ticker is ABMD

What exchange is Abiomed traded on?

The company's shares trade on the NASDAQ stock exchange

Where are Abiomed's headquarters?

They are based in Danvers, Massachusetts

How many employees does Abiomed have?

There are 1001-5000 employees working at Abiomed

What is Abiomed's website?

It is abiomed.com

What type of sector is Abiomed?

Abiomed is in the Healthcare sector

What type of industry is Abiomed?

Abiomed is in the Medical Appliances & Equipment industry

Who are Abiomed's peers and competitors?

The following five companies are Abiomed's industry peers:

- Integer

- Orthofix Medical

- EDAP TMS S.A.

- Silk Road Medical

- Nanosonics